Trade Quince Therapeuticks Inc - QNCX CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0436 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023485% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001262% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.2782 |
| Open | 1.2482 |
| 1-Year Change | 19.23% |
| Day's Range | 1.2382 - 1.2782 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 31, 2025 | 1.2782 | 0.0000 | 0.00% | 1.2782 | 1.3082 | 1.2582 |
| Mar 28, 2025 | 1.3082 | -0.0200 | -1.51% | 1.3282 | 1.3482 | 1.3082 |
| Mar 27, 2025 | 1.3882 | 0.0200 | 1.46% | 1.3682 | 1.3882 | 1.2982 |
| Mar 26, 2025 | 1.3482 | 0.0100 | 0.75% | 1.3382 | 1.3482 | 1.3082 |
| Mar 25, 2025 | 1.3082 | -0.0100 | -0.76% | 1.3182 | 1.3682 | 1.3082 |
| Mar 24, 2025 | 1.3582 | 0.0100 | 0.74% | 1.3482 | 1.4182 | 1.3382 |
| Mar 21, 2025 | 1.3382 | 0.0200 | 1.52% | 1.3182 | 1.3582 | 1.3082 |
| Mar 20, 2025 | 1.3482 | 0.0000 | 0.00% | 1.3482 | 1.3682 | 1.3282 |
| Mar 19, 2025 | 1.3482 | 0.0900 | 7.15% | 1.2582 | 1.3682 | 1.2582 |
| Mar 18, 2025 | 1.3082 | -0.0300 | -2.24% | 1.3382 | 1.3382 | 1.2882 |
| Mar 17, 2025 | 1.3382 | -0.0300 | -2.19% | 1.3682 | 1.3782 | 1.3382 |
| Mar 14, 2025 | 1.3982 | 0.0200 | 1.45% | 1.3782 | 1.3982 | 1.3782 |
| Mar 13, 2025 | 1.3782 | -0.0700 | -4.83% | 1.4482 | 1.4482 | 1.3582 |
| Mar 12, 2025 | 1.4382 | 0.0400 | 2.86% | 1.3982 | 1.4582 | 1.3782 |
| Mar 11, 2025 | 1.4182 | 0.0200 | 1.43% | 1.3982 | 1.4282 | 1.3682 |
| Mar 10, 2025 | 1.4182 | -0.0300 | -2.07% | 1.4482 | 1.4682 | 1.3882 |
| Mar 7, 2025 | 1.4582 | 0.0100 | 0.69% | 1.4482 | 1.4782 | 1.4482 |
| Mar 6, 2025 | 1.4882 | 0.0400 | 2.76% | 1.4482 | 1.4882 | 1.4482 |
| Mar 5, 2025 | 1.4982 | 0.0600 | 4.17% | 1.4382 | 1.5182 | 1.4282 |
| Mar 4, 2025 | 1.4482 | 0.0300 | 2.12% | 1.4182 | 1.4582 | 1.4082 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Cortexyme Inc. Company profile
About Cortexyme Inc
Cortexyme, Inc. is a clinical stage biopharmaceutical company that is focused on providing disease-modifying therapeutics to treat Alzheimer's and other degenerative diseases. The Company provides 3CLpro inhibitor, COR803 product, is a lead compound for treatment of coronavirus infections. The Company’s products pipeline includes drug candidates for the treatment of central nervous system (CNS) disorders including Alzheimer’s disease; for the treatment of oncology applications including the prevention of oral squamous cell carcinoma, and for the treatment of underserved and chronic conditions such as periodontitis. The Company’s COR388 is for the treatment of Alzheimer’s disease and Parkinson's disease. The Company's COR588 is in Phase I clinical trial and targeting to use in the treatment of periodontal disease and other P. gingivalis-related indications. The Company is also developing COR588, is a second-generation brain penetrant lysine gingipain inhibitor.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Cortexyme Inc revenues was not reported. Net loss increased 17% to $89.9M. Higher net loss reflects Stock-based Compensation in R&D increase from $7M to $15.1M (expense), Stock-based Compensation in GA increase of 99% to $14.8M (expense), General and administrative - Balancing increase of 45% to $14.7M (expense).
| Industry: | Biotechnology & Medical Research (NEC) |
601 Gateway Boulevard, Suite 1250
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com